Adi Sfadia
Analyst · Rodman Renshaw. Please go ahead
Thank you, Yona and good morning and good afternoon everyone. I would like to remind everyone that the financial results are presented both on a GAAP and non-GAAP basis. We regularly use supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. We believe this non-GAAP financial measure provide consistent and comparable measures to help investors understand our current and future operating performance. Non-GAAP financial measures exclude mainly the effect of stock-based compensation, amortization of purchased intangibles, restructuring expenses, litigation expenses related to trade secret claims, impairment of goodwill and long-lived assets, and net income or loss on discontinued operations. The consolidation table in our press release highlights this data and our non-GAAP information presented excludes these items. I will start with some brief highlights on our 2016 full year results. Total 2016 revenues were $279.6 million compared to $197.5 million in 2015 about 42% increase. We are reporting full year operating income of $755,000 compared to an operating loss of 43.7% in 2015. The GAAP loss for 2016 was $5.3 million, or $0.10 per diluted share compared to a loss of $52.3 million or $1.19 per diluted share in 2015. On a non-GAAP basis, we are reporting full year operating income of $11.7 million and net income of $5.6 million or $0.11 per diluted share compared to a non-GAAP operating loss of $3.4 million or a loss of $11.08 or $0.27 per diluted share in 2016. Moving to our financial highlights for the first quarter of 2016. Revenues for the first quarter were $80.3 million compared to $67.7 million in the same quarter of 2015, and $78.6 million in the previous quarter. In the fourth quarter of 2016, we had lower than expected revenues in the FITEL projects in Peru mainly due to the temporary delays in the project implementations. Our GAAP gross margin in the first quarter of 2016 were 30% of revenues compared with 15% in the same quarter of 2016, which included impairment of long-lived assets. Excluding the impairments the gross margin that quarter were 30%. It was the same in the previous quarter. R&D expenses were $6.5 million compared to 3.7 million in the same quarter of 2015 and $6.4 million in the previous quarter. During the first quarter of 2015, we recorded about $2 million of R&D grants as an outcome of approval of additional R&D projects by the office of the Chief Scientist in Israel. Sales and marketing expenses remained at $6.2 million, the same level as in the same quarter of 2015 and as in the previous quarter. G&A expenses were $5 million compared to $3.4 million in the same quarter of 2015 and $11.3 million in the previous quarter, which included an allowance for Doubtful Accounts for $4.6 million with respect to a governmental customer in Venezuela. In addition, G&A expenses in the third quarter of 2016 included $2 million of legal expenses due to a trade secret claim filed in the U.S. by Gilat against former employees. Those legal expenses amounted to $900,000 in Q4, 2016 and $100,000 in Q4, 2015. Total operating expenses on a GAAP basis for the fourth quarter were $17.7 million compared to $13.8 million in the same quarter 2015 and $23.9 million in the previous quarter. GAAP operating income was $6.5 million in the fourth quarter compared to an operating loss of $3.4 million in the same quarter of 2016 and operating loss of $222,00 in the previous quarter. GAAP net income was $4.5 million or $0.08 per diluted share compared to net loss of $5.2 million or $0.12 per diluted share in the same quarter of 2015 and net loss of $2,2 million or a loss of $0.04 per diluted share in the previous quarter. On a non-GAAP basis operating income for the fourth quarter was $9 million same as the fourth quarter of 2015. Operating income for the previous quarter was $3.3 million. Non-GAAP net income was $7 million or $0.17 per diluted share for the fourth quarter of 2016 compared with to net income of $7.1 million or $0.16 per diluted share in the same quarter of 2015. Net income for the previous quarter was $1.4 million or $0.02 per diluted share. Adjusted EBITDA for the fourth quarter of 2016 was $10.8 million compared to an adjusted EBITDA of $11.2 million in the same quarter of 2015. Adjusted EBITDA for the previous quarter was $5.2 million. As of December 31, 2016 our total cash and equivalent including restricted cash net of short-term bank loans and credit was $111.6 million, a decrease of $14.5 million on the previous quarter. DSOs which exclude receivables and revenues of our service segment, increased to 89 days compared to 83 days in the previous quarter. Our shareholders' equity at the end of the quarter totaled about $210 million. That concludes our financial review for the quarter and now I would like to turn the call over to Yona. Yona?